Finally, IHC analysis showed that the expression levels of p-ERK1/2 and p-MEK1/2 were higher in primary tissues with high CTCs than those of BC patients with low CTCs (Fig. 4G). This evidence concerns the gene MAP2K1 and breast cancer.